Latest news
Loading news…
Aerium Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Boston, Massachusetts, United States Founded 2021 1-10 employees For Profit
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- IT spend
- $297K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 7
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Closed
- Oct 16, 2024
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 1.6
- Trend (30d)
- 4.5
- Trend (90d)
- -0.7
Key People at Aerium Therapeutics
Senior Director, Medical Monitor
13
professional contacts at Aerium Therapeutics
Contact execs at Aerium Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aerium Therapeutics
Loading news…
FAQs about Aerium Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.